NumFin

Dong Sung Bio Pharm.Co.,Ltd.

符号: 002210.KS

KSC

5240

KRW

今天的市场价格

  • -57.7739

    市盈率

  • -0.8344

    PEG比率

  • 119.82B

    MRK市值

  • 0.00%

    DIV收益率

Dong Sung Bio Pharm.Co.,Ltd. (002210-KS) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Dong Sung Bio Pharm.Co.,Ltd. (002210.KS). 的默认数据。公司收入显示 79053.1 M 的平均值，即 0.019 % 增长率。整个期间的平均毛利润为 37951.544 M，即 0.044 %. 平均毛利率为 0.488 %. 公司去年的净收入增长率为 -0.023 %，等于 -3.260 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Dong Sung Bio Pharm.Co.,Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.068. 在流动资产领域，002210.KS 的报告货币为60814.86. 这些资产中的很大一部分，即 6435.381 是现金和短期投资。与去年的数据相比，该部分的变化率为0.572%. 公司的长期投资虽然不是其重点，但以报告货币计算的7719.611（如果有的话）为7719.611。这表明与上一报告期相比，1413.020% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 18522.411. 这一数字表明，0.168% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 39802.314. 这方面的年同比变化率为 -0.070%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为31290.912，存货估值为 19477.06，商誉估值为 0（如有. 无形资产总额（如果有）按 978.8 估值. 应付账款和短期债务分别为 11261.11 和 24732.54. 债务总额为43272.81，债务净额为 36837.43. 其他流动负债为 8850.2，加上总负债 75170.97. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

21733.896435.44093.85142.8
23422.8
22853.6
32227.5
17931.1
20164.6
23372.6
32212
21256.9
22025
16438.8
19043.9
13732.7
15065.4
14838.1

balance-sheet.row.short-term-investments

-3073.9002002.6
9070.6
18575.2
30016.6
13883.4
17259.3
18723.2
25038.6
13965.1
12213.2
8291.3
11649
10807.9
9824
9074.7

balance-sheet.row.net-receivables

127499.5431290.935361.629324.5
27803
33260.6
38202.1
40257.5
42048.1
42684.4
42077.5
45207.2
50487.8
47433.6
46332.3
50017.4
0
0

balance-sheet.row.inventory

72346.5219477.114933.815519.1
20281.7
23283.5
17359.9
16332.3
14867.5
10963.6
12785.2
12686.7
11641
11175.6
10554
12081.5
10325.4
10173.4

balance-sheet.row.other-current-assets

16601.773611.500
0
0
0
0
0
0
0
0
0
0
0
0
47178.3
45183.5

balance-sheet.row.total-current-assets

238181.7260814.954389.249986.3
71507.5
79397.7
87789.5
74520.9
77080.3
77020.7
87074.7
79150.9
84153.8
75047.9
75930.1
75831.7
72569
70195

balance-sheet.row.property-plant-equipment-net

172690.3242725.543960.437377.8
37312.9
34175.6
34506.9
34401.7
33214.2
31883.3
32171.2
32198.6
32176.9
30617.4
47157.2
47700
48247.6
28254.1

balance-sheet.row.goodwill

0000
0
0
0
282.9
282.9
282.9
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

3645.02978.8855.8942.7
830
738.8
882.3
903.8
705.4
770.6
453.7
751.4
834.7
1166.2
741.6
812.2
758.4
168.3

balance-sheet.row.goodwill-and-intangible-assets

3645.02978.8855.8942.7
830
738.8
882.3
1186.7
988.3
1053.5
453.7
751.4
834.7
1166.2
741.6
812.2
758.4
168.3

balance-sheet.row.long-term-investments

12525.067719.6510.2-1606.9
-8716.9
-18210.1
-27258.5
-13329.7
-16749.5
-18230.4
-24858.4
-13364.9
-10407.8
-6772.6
-10083.5
-8450.2
-7736.9
-6393.6

balance-sheet.row.tax-assets

11078.520-510.217882
24784.6
1158
809.3
27405.3
30853.2
32389
39163.8
28163.8
26683.1
24518.2
1328
373.8
53.3
1568.7

balance-sheet.row.other-non-current-assets

18636.952734.68496.60
0
34470.4
43466.5
0
0
0
259
190.5
192.9
0
12469.5
11638.4
10678.2
9624.8

balance-sheet.row.total-non-current-assets

218575.8754158.453312.954595.6
54210.7
52332.8
52406.6
49664
48306.1
47095.4
47189.4
47939.5
49479.8
49529.2
51612.8
52074.2
52000.5
33222.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

456757.59114973.3107702.1104581.9
125718.2
131730.5
140196.1
124184.9
125386.4
124116.1
134264.1
127090.4
133633.7
124577.1
127542.9
127905.9
124569.6
103417.4

balance-sheet.row.account-payables

47580.1611261.188526858.8
9728.6
9978.2
10187.4
11453.5
11100.1
10338.4
12800.3
9054.1
13850.8
12397.7
12104.5
9421.3
9676.3
9543.9

balance-sheet.row.short-term-debt

112670.1924732.52927419714
14046.3
15852.6
20309.8
19183
20096.3
37463.6
37596.6
37103.8
34787.3
33294.7
29964.6
29546.8
20037.7
24325.2

balance-sheet.row.tax-payables

66.530418.8262.1
103.7
322.6
469.1
341.4
455.4
513.2
9875
576.1
678.6
784.5
4748.7
550.1
665.8
1489.1

balance-sheet.row.long-term-debt-total

52132.3418522.47761.99600.8
12349.1
11875.4
22342.7
12040.9
19971.1
2021.6
2460.6
1683.5
3206.1
1635.5
2762.5
1631.5
6718.3
7056.1

Deferred Revenue Non Current

17174.1117.909113.3
8388.2
0
0
10756.2
10719.1
9469.4
9849
9519.5
8976.9
9112.3
0
0
9677.1
0

balance-sheet.row.deferred-tax-liabilities-non-current

10739.73---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

60212.78850.29183.73729.5
4560.3
3600.9
16172.8
0
0
0
0
0
0
0
0
4228.3
5640
0

balance-sheet.row.total-non-current-liabilities

95537.1530327.117321.620552.3
22937
21082.6
35572.5
23230.1
31304.9
13116.3
13709.6
12889.9
15153.5
13456
17365.4
16189.6
20726.8
18198.2

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

231.8117.9104.155.7
70.1
78.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

289693.77517164892.858141.5
70770.1
61632.1
82711.7
59914.2
69765.8
66380.9
78658.9
65610.9
70751.4
64375.9
68858.5
59936.1
56746.7
57278.5

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

104403.88261012610126101
26101
26070.7
24756.6
24756.6
22404.8
22404.8
21766.5
21766.5
21128.2
21128.2
21128.2
21128.2
21128.2
21128.2

balance-sheet.row.retained-earnings

4190.1-3006.91153.1-2570.8
-10992
-779.4
7493.8
17847.1
18019.1
20133.6
19497.9
31220
34114.3
31913.1
10768.2
19250.2
19226.6
16114.7

balance-sheet.row.accumulated-other-comprehensive-income-loss

11151.022787.82787.82787.8
2787.8
5745.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

47318.8913920.512767.520122.4
37051.3
39061.9
25234.1
21667
15196.8
15196.8
14340.9
8493
7639.8
7159.9
26788.1
27591.4
27468.1
8896.1

balance-sheet.row.total-stockholders-equity

167063.8939802.342809.346440.4
54948
70098.4
57484.4
64270.7
55620.6
57735.2
55605.2
61479.4
62882.2
60201.2
58684.4
67969.8
67822.9
46138.9

balance-sheet.row.total-liabilities-and-stockholders-equity

456757.59114973.3107702.1104581.9
125718.2
131730.5
140196.1
124184.9
125386.4
124116.1
134264.1
127090.4
133633.7
124577.1
127542.9
127905.9
124569.6
103417.4

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

167063.8939802.342809.346440.4
54948
70098.4
57484.4
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

456757.59---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

9451.157719.6510.2395.7
353.8
365.1
2758.1
553.7
509.8
492.8
180.2
600.2
1805.4
1518.6
1565.6
2357.7
2087.1
2681.1

balance-sheet.row.total-debt

164820.3943272.837035.829314.8
26395.4
27727.9
42652.5
31223.9
40067.4
39485.1
40057.2
38787.3
37993.4
34930.2
32727.1
31178.3
26756.1
31381.3

balance-sheet.row.net-debt

147179.1636837.43294226174.6
12043.3
23449.5
40441.5
27176.2
37162.1
34835.7
32883.9
31495.5
28181.5
26782.7
25332.3
28253.5
21514.7
25617.9

现金流量表

在 Dong Sung Bio Pharm.Co.,Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.153 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 1519.79. 公司的投资活动产生了现金使用净额，按报告货币计算达到-927712649.000. 与上一年相比， -2.453 发生了变化. 在同一时期，公司记录了 2045.99, 35.2 和 -1229.62，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 8796.97，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

-2073.91-2073.9-2121.7-4312.8
-14079.1
-8385.2
-5744.6
-198.3
-1660.4
454.8
-10946.9
-1988.2
3192.1
1701.1
-7937.3
568.4
3656.6
2656

cash-flows.row.depreciation-and-amortization

2082.0920462119.72222.6
2098
2107.6
1986.4
1813.1
1644.8
1608.8
1542.3
1464.9
1589.5
1507.5
1560.1
1316
1386
1465.2

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-5165.38-5165.4-4348.3-2543.3
6519.5
-5843.7
205.4
-2069.5
-5864.9
-1349.2
1103.1
-4427.2
-904.2
-7049
5759
-9896.1
-5890.6
-2527.9

cash-flows.row.account-receivables

2887.72887.7-4280.9-1791.5
4836.5
3282.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-3965.32-3965.3629.74466.7
2926
-6132
-1029.8
-2785.5
-4451.6
1084.9
-517.8
-1045.7
-680.8
-621.6
1523.2
-1781.5
-274.3
-676.4

cash-flows.row.account-payables

1519.791519.81995-2870.6
-247.9
-212.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-5607.55-5607.6-2692.1-2348
-995.2
-2781.9
1235.3
716
-1413.3
-2434.1
1620.9
-3381.4
-223.4
-6427.3
4235.7
-8114.5
-5616.3
-1851.5

cash-flows.row.other-non-cash-items

863.87900467.61882
10471.3
3815.3
4945.9
2253.4
2536.2
-10034
11951.8
2382.9
-1072.8
1197.1
5253.1
2990.7
482.7
1324.1

cash-flows.row.net-cash-provided-by-operating-activities

-4293.33000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-923.56-923.6-642.9-2323.5
-6922
-1422
-2126.8
-3004.3
-2841.6
-646.6
-1287.8
-1188.2
-1844.7
-828.6
-947
-949.5
-1102.7
-2439.2

cash-flows.row.acquisitions-net

32.7818.274.3-197.7
2143
-99.8
197
-372.3
-104.3
65.2
-23.4
150
-209.7
-437.9
-91.6
-215.7
6920.3
4119.6

cash-flows.row.purchases-of-investments

-48.49-57.5-56.2-10994.9
-51719.5
-73608.5
-92696.8
-32995.6
-51496.2
-55896.9
-64928.1
-26577.1
-33572
-39760.5
-53803.5
-15120.5
-3890.8
-11066

cash-flows.row.sales-maturities-of-investments

-32.7802019.914989.6
49947.7
84373
75772.1
36717.9
53038.9
63234.6
54421.7
26652
29342.4
43526.7
53884.3
14795
2930.3
1474.4

cash-flows.row.other-investing-activites

44.3435.2-756.9-11173.2
912.2
103.6
-210.1
211.3
470.2
-317.3
-99
-398.3
14.5
903.3
555.7
46.6
381.7
-39.9

cash-flows.row.net-cash-used-for-investing-activites

-927.71-927.7638.3-9699.8
-5638.6
9346.4
-19064.6
557.1
-933
6439
-11916.6
-1361.5
-6269.4
3403
-402.2
-1444.1
5238.8
-7951.1

cash-flows.row.debt-repayment

-33936.52-1229.6-44052.3-26435.5
-27917.2
-27580.9
-25413
-19854.5
-37660.6
-30941.4
-12680.8
-14519.2
-13774.7
-12949.5
-16046.8
-7237.7
-4625.2
-12274.3

cash-flows.row.common-stock-issued

0008455.4
-1.4
-26.3
0
0
0
1494.2
7164
1491.5
0
0
17430.4
0
0
2784.3

cash-flows.row.common-stock-repurchased

00-1996.4-2990.4
-2000.3
0
0
0
0
0
14080.4
15054.9
0
0
-899.3
0
0
12470

cash-flows.row.dividends-paid

000-8455.4
-1.4
0
0
0
0
0
-548.9
-529.7
-529.7
-529.7
-544.7
-544.7
-544.7
-685.5

cash-flows.row.other-financing-activites

41503.8887975028930657.7
26617.6
28619.3
41226.4
18866.8
40117.7
29673.1
-58
40
19797.4
13333.8
297.9
11931
-225.6
-53

cash-flows.row.net-cash-used-provided-by-financing-activities

7567.357567.44240.21231.8
-3302.6
1012.1
15813.4
-987.7
2457.2
225.9
7956.6
1537.5
5492.9
-145.4
237.4
4148.5
-5395.6
2241.5

cash-flows.row.effect-of-forex-changes-on-cash

-4.71-4.7-42.37.6
-83.4
14.9
21.2
-225.8
76.1
130.6
191.4
-128.4
-363.8
138.4
0
0
0
0

cash-flows.row.net-change-in-cash

2341.62341.6953.6-11211.9
-4015
2067.5
-1836.7
1142.4
-1744.1
-2524
-118.4
-2520
1664.3
752.7
4470
-2316.6
-522
-2792.3

cash-flows.row.cash-at-end-of-period

17641.236435.44093.83140.2
14352.1
4278.4
2210.9
4047.7
2905.3
4649.4
7173.4
7291.8
9811.8
8147.5
7394.8
2924.8
5241.4
5763.4

cash-flows.row.cash-at-beginning-of-period

15299.634093.83140.214352.1
18367.1
2210.9
4047.7
2905.3
4649.4
7173.4
7291.8
9811.8
8147.5
7394.8
2924.8
5241.4
5763.4
8555.7

cash-flows.row.operating-cash-flow

-4293.33-4293.3-3882.6-2751.5
5009.7
-8305.9
1393.3
1798.8
-3344.3
-9319.5
3650.2
-2567.5
2804.6
-2643.3
4634.8
-5021
-365.3
2917.3

cash-flows.row.capital-expenditure

-923.56-923.6-642.9-2323.5
-6922
-1422
-2126.8
-3004.3
-2841.6
-646.6
-1287.8
-1188.2
-1844.7
-828.6
-947
-949.5
-1102.7
-2439.2

cash-flows.row.free-cash-flow

-5216.9-5216.9-4525.5-5075.1
-1912.3
-9727.9
-733.5
-1205.5
-6186
-9966
2362.3
-3755.7
959.9
-3471.9
3687.8
-5970.5
-1468
478.1

利润表行

Dong Sung Bio Pharm.Co.,Ltd. 的收入与上期相比变化了 -0.051%。据报告, 002210.KS 的毛利润为 40649.65。该公司的营业费用为 40053.24，与上年相比变化了 -11.293%. 折旧和摊销费用为 2045.99，与上一会计期间相比变化了 -0.035%. 营业费用报告为 40053.24，显示-11.293% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长1.292%. 营业收入为 596.4，与上年相比变化了-1.292%. 净利润的变化率为 -0.023%。去年的净收入为-2073.91.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

88593.5988593.693328.284407.7
87799.9
86536.8
91912.7
82385.2
79720.9
74660.4
73157.9
75175.3
84581
78442.1
71926
68724.2
62231.4
60319.5

income-statement-row.row.cost-of-revenue

47447.6447943.951272.850864
53650.7
53460.2
56718.2
46281.6
42624.9
38182.4
37893.9
36210.9
42056.7
33020.8
31919.4
27614.8
25271.4
23739.8

income-statement-row.row.gross-profit

41145.9540649.642055.433543.6
34149.2
33076.5
35194.5
36103.6
37096
36477.9
35264
38964.4
42524.3
45421.3
40006.6
41109.4
36960
36579.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

4169.12---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

12376.07---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

24762.64---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-20425.25-2211220012364.1
10995.7
13821.9
243.5
327.6
796.9
479.6
-977.7
420.2
1340.9
494.9
-618.7
372.3
202.6
206.5

income-statement-row.row.operating-expenses

1866640053.245152.438842.7
37820
40608.3
37001.8
35148.5
39385.6
35281
37094.8
40931.4
39271.3
42313.6
43152.8
39979.5
35352.2
34928

income-statement-row.row.cost-and-expenses

77055.4187997.296425.289706.7
91470.7
94068.5
93719.9
81430.1
82010.5
73463.5
74988.7
77142.3
81328
75334.4
75072.2
67594.2
60623.6
58667.7

income-statement-row.row.interest-income

63.2663.347.176.7
25.5
60.4
23.6
5.9
7.8
12.1
155.1
72.7
47.3
98.5
347.5
260.9
548.2
349.1

income-statement-row.row.interest-expense

2240.912240.91307.8712.2
850.3
1403.3
1689.2
1466.7
1396.1
1423.2
1564.3
1813.4
2284.2
2002.6
2075.4
1701.4
1828.5
1965.5

income-statement-row.row.selling-and-marketing-expenses

24762.64---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-1462.29-1462.3191.2919.7
-7135.1
-1233.8
-4885.8
-1521.4
-253.4
-452.8
-1164.5
-1147.9
338.8
-1359.1
-1905.1
-454
3628.6
1819.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-20425.25-2211220012364.1
10995.7
13821.9
243.5
327.6
796.9
479.6
-977.7
420.2
1340.9
494.9
-618.7
372.3
202.6
206.5

income-statement-row.row.total-operating-expenses

-1462.29-1462.3191.2919.7
-7135.1
-1233.8
-4885.8
-1521.4
-253.4
-452.8
-1164.5
-1147.9
338.8
-1359.1
-1905.1
-454
3628.6
1819.8

income-statement-row.row.interest-expense

2240.912240.91307.8712.2
850.3
1403.3
1689.2
1466.7
1396.1
1423.2
1564.3
1813.4
2284.2
2002.6
2075.4
1701.4
1828.5
1965.5

income-statement-row.row.depreciation-and-amortization

12820.2620462119.73980.6
2256.7
3367.7
1986.4
1813.1
1644.8
1608.8
1542.3
1464.9
1589.5
1507.5
1560.1
1316
1386
1465.2

income-statement-row.row.ebitda-caps

13416.67---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

596.4596.4-2041.8-5299
-3670.8
-7531.8
-1807.3
955.1
-2289.6
1196.9
-1830.8
-1967
3253.1
3595.2
-3146.2
1129.9
1607.9
1651.8

income-statement-row.row.income-before-tax

-865.89-865.9-1850.6-4379.3
-10805.9
-8765.5
-6693.1
-566.3
-2543.1
744.1
-2995.3
-3114.9
3591.9
1748.6
-5051.3
676
5236.4
3471.5

income-statement-row.row.income-tax-expense

1208.021208271.1-66.5
3273.3
-380.3
-948.5
-368
-882.6
289.2
7951.7
-1126.7
399.8
47.5
2886.1
107.6
1579.8
815.6

income-statement-row.row.net-income

-2073.91-2073.9-2121.7-4312.8
-14079.1
-8385.2
-5744.6
-198.3
-1660.4
454.8
-10946.9
-1988.2
3192.1
1701.1
-7937.3
568.4
3656.6
2656
类似股票
您可能还对以下内容感兴趣：
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
TLLTF
TILT Holdings Inc..
0.0333 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
546.8 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
871.2 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.616 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1024.1 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC

常见问题

什么是 Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) 总资产是多少？

Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) 总资产为 114973284037.000.

什么是企业年收入？

年收入为 43786401591.000.

企业利润率是多少？

公司利润率为 0.464.

什么是公司自由现金流？

自由现金流为 -228.151.

什么是企业净利润率？

净利润率为 -0.023.

企业总收入是多少？

总收入为 0.007.

什么是 Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 -2073909512.000.

公司总债务是多少？

债务总额为 43272811605.000.

营业费用是多少？

运营支出为 40053242263.000.

公司现金是多少？

企业现金为 6435381432.000.